SSelectStock

VIJAYAVijaya Diagnostic Centre Limited

Healthcare · Diagnostics & Research · NSE · as of 2026-09-11 (delayed ~30 min in market hours)

Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. The company offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T services. It also provides health checkups and home sample collection services. Vijaya Diagnostic Centre Limited was founded in 1981 and is based in Hyderabad, India.

1,502.00
0.21%
72Strong

Mkt Cap
₹15,467 Cr
P/E
89.7
P/B
16.3
Div Yield
0.15%
52W High
₹1,578.00
52W Low
₹848.00

Price & Volume

Loading chart…

Key Ratios

Market Cap (₹ cr)15,466.70
P/E89.67
P/B16.33
PEG2.43
ROE %19.70
ROCE %17.80
Debt / Equity0.44
EPS16.75
Revenue Growth %26.60
Profit Growth %38.00
Dividend Yield %0.15
Promoter Holding %52.46
FII Holding %39.88
DII Holding %
Beta0.34

“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.

Active Pattern Signals

BUYConviction 85%

Why buy

  • Revenue growth: 26.6% YoY
  • Profit growth: 38.0% YoY
  • ROE: 19.7%
  • RSI: 58
  • Price vs EMA21: above
  • Price vs SMA50: above
  • Pullback to 21-EMA signal (setup quality 75%)

Bull case

  • Revenue growth: 26.6% YoY
  • Profit growth: 38.0% YoY
  • ROE: 19.7%
  • RSI: 58

Bear case

  • Valuation vs sector: P/E 89.7 vs sector 52.7
  • PEG ratio: 2.43
  • MACD: bearish
  • Volume: 0.7x 20-day average

Key risks

  • Valuation vs sector: P/E 89.7 vs sector 52.7
  • PEG ratio: 2.43

Algorithmic analysis for research only — not SEBI-registered investment advice.

Trade Plan

Entry (CMP)
₹1,502.00
Stop Loss
₹1,425.60
risk 5.1%
Target 1 (1.5R)
₹1,616.60
+7.6%
Target 2 (3R)
₹1,731.20
+15.3%
Support (20d)
₹1,440.00
Resistance (52w)
₹1,578.00
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹76.40/share
ATR (volatility)
₹46.91
avg daily range

Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹46.91). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.

Score Breakdown

Fundamental73
Technical69
Momentum74
Risk (safety)74

Peers — Healthcare

GKSL 1.23%
79
NEPHROPLUS 2.42%
74
KOVAI 1.41%
73
SAILIFE 0.38%
73
METROPOLIS 1.70%
73
SURAKSHA 1.25%
72